20-259226-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_207469.3(DEFB132):c.208C>T(p.Leu70Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000856 in 1,612,392 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207469.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DEFB132 | NM_207469.3 | c.208C>T | p.Leu70Phe | missense_variant | 2/2 | ENST00000382376.4 | NP_997352.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DEFB132 | ENST00000382376.4 | c.208C>T | p.Leu70Phe | missense_variant | 2/2 | 1 | NM_207469.3 | ENSP00000371813.3 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152062Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000954 AC: 24AN: 251478Hom.: 0 AF XY: 0.0000809 AC XY: 11AN XY: 135914
GnomAD4 exome AF: 0.0000589 AC: 86AN: 1460210Hom.: 1 Cov.: 34 AF XY: 0.0000564 AC XY: 41AN XY: 726438
GnomAD4 genome AF: 0.000342 AC: 52AN: 152182Hom.: 1 Cov.: 33 AF XY: 0.000417 AC XY: 31AN XY: 74428
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 16, 2024 | The c.208C>T (p.L70F) alteration is located in exon 2 (coding exon 2) of the DEFB132 gene. This alteration results from a C to T substitution at nucleotide position 208, causing the leucine (L) at amino acid position 70 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at